123 related articles for article (PubMed ID: 6744327)
1. Augmentation of autologous antibody to human melanoma following acid dissociation and ultrafiltration of serum.
Kirkwood JM; Vlock DR
Cancer Res; 1984 Sep; 44(9):4177-82. PubMed ID: 6744327
[TBL] [Abstract][Full Text] [Related]
2. Incidence of serum antibody reactivity to autologous head and neck cancer cell lines and augmentation of antibody reactivity following acid dissociation and ultrafiltration.
Vlock DR; Scalise D; Schwartz DR; Richter DE; Krause CJ; Baker SR; Carey TE
Cancer Res; 1989 Mar; 49(6):1361-5. PubMed ID: 2924293
[TBL] [Abstract][Full Text] [Related]
3. Isolation and immunochemical characterization of antibodies from the sera of cancer patients which are reactive against human melanoma cell membranes by affinity chromatography.
Gupta RK; Silver HK; Reisfeld RA; Morton DL
Cancer Res; 1979 May; 39(5):1683-95. PubMed ID: 427806
[TBL] [Abstract][Full Text] [Related]
4. Serial studies of autologous antibody reactivity to melanoma. Relationship to clinical course and circulating immune complexes.
Vlock DR; Kirkwood JM
J Clin Invest; 1985 Aug; 76(2):849-54. PubMed ID: 3875634
[TBL] [Abstract][Full Text] [Related]
5. [Serological analysis of melanoma patients receiving autologous melanoma cell vaccines].
Watanabe T
Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt):261-72. PubMed ID: 6881976
[TBL] [Abstract][Full Text] [Related]
6. Prolonged survival for melanoma patients with elevated IgM antibody to oncofetal antigen.
Jones PC; Sze LL; Liu PY; Morton DL; Irie RF
J Natl Cancer Inst; 1981 Feb; 66(2):249-54. PubMed ID: 6935475
[TBL] [Abstract][Full Text] [Related]
7. Induction of IgG antibodies directed to a M(r) 31,000 melanoma antigen in patients immunized with vaccinia virus melanoma oncolysates.
Berthier-Vergnes O; Portoukalian J; Lefthériotis E; Doré JF
Cancer Res; 1994 May; 54(9):2433-9. PubMed ID: 8162593
[TBL] [Abstract][Full Text] [Related]
8. Oncofetal antigen: a tumor-associated fetal antigen immunogenic in man.
Irie RF; Giuliano AE; Morton DL
J Natl Cancer Inst; 1979 Aug; 63(2):367-73. PubMed ID: 88539
[TBL] [Abstract][Full Text] [Related]
9. Changes in distribution of human malignant melanoma membrane antigens in the presence of human antibody by immunofluorescence.
Leong SP; Sutherland CM; Krementz ET
Cancer Res; 1977 Jan; 37(1):293-8. PubMed ID: 318607
[TBL] [Abstract][Full Text] [Related]
10. Antibody-induced movement of common melanoma membrane antigens on the surface of unfixed human melanoma cells.
Leong SP; Cooperband SR; Deckers PJ; Sutherland CM; Cesare JF; Krementz ET
Cancer Res; 1979 Jun; 39(6 Pt 1):2125-31. PubMed ID: 376115
[TBL] [Abstract][Full Text] [Related]
11. Production of antisera with specificity for malignant melanoma and human fetal skin.
Fritze D; Kern DH; Drogemuller CR; Pilch YH
Cancer Res; 1976 Feb; 36(2 Pt 1):458-66. PubMed ID: 56991
[TBL] [Abstract][Full Text] [Related]
12. Mouse monoclonal antibody to a melanoma-carcinoma-associated antigen synthesized by a human melanoma cell line propagated in serum-free medium.
Chee DO; Yonemoto RH; Leong SP; Richards GF; Smith VR; Klotz JL; Goto RM; Gascon RL; Drushella MM
Cancer Res; 1982 Aug; 42(8):3142-7. PubMed ID: 7046918
[TBL] [Abstract][Full Text] [Related]
13. 707-AP peptide recognized by human antibody induces human leukocyte antigen A2-restricted cytotoxic T lymphocyte killing of melanoma.
Takahashi T; Irie RF; Nishinaka Y; Hoon DS
Clin Cancer Res; 1997 Aug; 3(8):1363-70. PubMed ID: 9815820
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies to human melanoma-associated antigens: an amplified enzyme-linked immunosorbent assay for the detection of antigen, antibody, and immune complexes.
Morgan AC; McIntyre RF
Cancer Res; 1983 Jul; 43(7):3155-9. PubMed ID: 6850625
[TBL] [Abstract][Full Text] [Related]
15. [Vaccine therapy of malignant melanoma. II. Serological evaluation of the immune responses to the injection using allogeneic melanoma cell vaccine].
Takeyama H; Watanabe T; Livingston PO
Gan To Kagaku Ryoho; 1983 Jul; 10(7):1624-33. PubMed ID: 6870307
[TBL] [Abstract][Full Text] [Related]
16. Tumor antigens isolated from a patient with vitiligo and T-cell-infiltrated melanoma.
Kiniwa Y; Fujita T; Akada M; Ito K; Shofuda T; Suzuki Y; Yamamoto A; Saida T; Kawakami Y
Cancer Res; 2001 Nov; 61(21):7900-7. PubMed ID: 11691810
[TBL] [Abstract][Full Text] [Related]
17. Prognostic role of antibody reactivity to melanoma.
Vlock DR; DerSimonian R; Kirkwood JM
J Clin Invest; 1986 Apr; 77(4):1116-21. PubMed ID: 3958183
[TBL] [Abstract][Full Text] [Related]
18. Melanoma-reactive human cytotoxic T lymphocytes derived from skin biopsies of delayed-type hypersensitivity reactions induced by injection of an autologous melanoma cell line.
Waanders GA; Rimoldi D; Liénard D; Carrel S; Lejeune F; Dietrich PY; Cerottini JC; Romero P
Clin Cancer Res; 1997 May; 3(5):685-96. PubMed ID: 9815737
[TBL] [Abstract][Full Text] [Related]
19. Suggestive evidence for in vivo binding of specific antitumor antibodies of human melanomas.
Gupta RK; Morton DL
Cancer Res; 1975 Jan; 35(1):58-62. PubMed ID: 1109797
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxic antibody reactivity in sera of melanoma patients against allogeneic and autologous cultured tumor cells and fibroblasts.
Brown JM; Shoffner PC; Tondreau SP; Matthews EJ; Terry WD; Rosenberg SA
Cancer Res; 1982 Jun; 42(6):2216-22. PubMed ID: 7074602
[No Abstract] [Full Text] [Related]
[Next] [New Search]